Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Harvard Business School
Accenture
Chubb
Mallinckrodt
Argus Health
Johnson and Johnson
Cerilliant
Federal Trade Commission
Medtronic

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205880

« Back to Dashboard

NDA 205880 describes SODIUM PHENYLACETATE AND SODIUM BENZOATE, which is a drug marketed by Ailex Pharms Llc, Maia Pharms Inc, and Navinta Llc, and is included in three NDAs. It is available from four suppliers. Additional details are available on the SODIUM PHENYLACETATE AND SODIUM BENZOATE profile page.

The generic ingredient in SODIUM PHENYLACETATE AND SODIUM BENZOATE is sodium benzoate; sodium phenylacetate. There are one thousand four hundred and fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.
Summary for 205880
Tradename:SODIUM PHENYLACETATE AND SODIUM BENZOATE
Applicant:Navinta Llc
Ingredient:sodium benzoate; sodium phenylacetate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 205880
Mechanism of ActionAmmonium Ion Binding Activity
Suppliers and Packaging for NDA: 205880
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 205880 ANDA Zydus Pharmaceuticals USA Inc. 68382-396 N 68382-396-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength10%;10% (5GM/50ML;5GM/50ML)
Approval Date:Aug 4, 2016TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
Merck
Healthtrust
Federal Trade Commission
Teva
Johnson and Johnson
Citi
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot